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The impact of lifestyle regulation on intellectual
property: packaging-related requirements and
other IP-restrictive measures
enrico bonadio
Introduction
The purpose of this chapter is to shed some light on the emerging, yet
largely unexplored, intersection between lifestyle regulation and intellectual
property (IP) law. It ﬁrst discusses the impact of a growing number of
regulatory measures aimed at reducing the consumption of products that
are harmful to people, such as tobacco, alcohol and HFSS foods, on IP
regimes. Such measures generally affect product presentation, limit adver-
tising, product availability and manufacturing and may also include ﬁscal
measures. Their adoption is triggered by a set of international regulatory
instruments, namely the legally binding WHO Framework Convention on
Tobacco Control (FCTC),1 as well as certain soft-law instruments such as
the WHO Strategies on Alcohol and Diets, the 2011 United Nations
Political Declaration on NCDs and the WHO Global Action Plan for the
Prevention and Control of NCDs 2013–2020.2
For our purposes, these measures can be grouped into four categories:
(i) measures related to the presentation of products (for example,
packaging-related requirements and display bans on cigarettes and
other products); (ii) measures related to advertising (for example, adver-
tising prohibitions or restrictions, or bans on aggressive marketing
1 WHO Framework Convention on Tobacco Control, opened for signature 16 June 2003,
2302 UNTS 166 (entered into force 27 February 2005) (‘WHO FCTC’).
2 See WHO Global Strategy to Reduce the Harmful Use of Alcohol (2010), WHA63.13;
WHO Global Strategy on Diet, Physical Activity and Health (2004), WHA57.17; Political
Declaration of the High-level Meeting of the General Assembly on the Prevention and
Control of Non-communicable Diseases, GA Res. 2, UN GAOR, 66th sess., 3rd plen. mtg,
UN Doc A/Res/66/2 (2012); WHO Global Action Plan for the Prevention and Control of
NCDs, Resolution WHA66.10 endorsed by the 66th WHO World Health Assembly.
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strategies, especially those targeting minors); (iii) measures restricting
availability of products (for example, sales restrictions to and by minors,
and bans of vending machines dispensing alcohol, cigarettes or
HFSS products); and (iv) measures related to the manufacturing of the
products (for example, bans on the use of certain ingredients including
trans-fats in foodstuffs, and bans on the use of additives in tobacco
such as ﬂavouring or colouring agents).
The purpose of these measures is to reduce the consumption of
products considered harmful and thus protect consumers’ health. Yet
these measures also have the effect of reducing the ability of tobacco,
alcohol and food manufacturers to produce, present, advertise and
market their products as they wish, and to make them appealing to
consumers. More importantly, as will be highlighted in the ﬁrst part of
this chapter, all these measures impair the ability of manufacturers to
fully exploit their IP assets, whether they are (a) registered or unregis-
tered trademarks afﬁxed on products and packaging; (b) copyrighted
works displayed on products or packaging; (c) distinctive trade dress and
get-up for products; (d) registered or unregistered designs incorporated
in products or packaging; or (e) patented inventions related to ingre-
dients and constituents or related to packaging. The second part of the
chapter will look at whether the inability of tobacco, alcohol and food
manufacturers to fully use their IP assets due to the introduction of
regulatory measures intended to curb consumption of their products
may encroach upon the exclusive rights offered by IP laws.
Finally, the last part of the chapter will discuss whether and to what
extent IP laws, and in particular patent procedures (in or outside
Europe), may be amended with a view to incentivizing companies to
produce and market healthier products in the ﬁeld of foodstuffs and
beverages.
Regulatory measures affecting IP in the ﬁelds
of tobacco, alcohol and foodstuffs
Regulatory measures often have a negative impact on business and trade,
as they make it more expensive and cumbersome for companies to
produce and market their products. This is particularly true of industries
that have, traditionally (and rather heavily), been regulated, such as
tobacco, alcohol and food. Recently, both within and outside Europe
there has been an increase in the regulatory burden placed on those
companies. Indeed, in the past years a wave of new regulatory measures
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have restricted the freedom of tobacco, alcohol and food companies to
produce, present, offer for sale, advertise and supply their products as
they wish. The ensuing limitation of commercial freedom is considered
by several governments as well as international and non-governmental
organizations as necessary to protect an overriding public interest – that
is, human health. The underlying idea behind most of these policies is
that states should take care of people’s health and therefore prohibit or
restrict commercial and industrial activities that could be harmful to it.
As mentioned above, all these measures – which affect virtually all
phases of the production chain (from manufacturing to supply) – also
restrict the ability of tobacco, alcohol and food manufacturers to fully
exploit their IP assets.
Measures relating to product presentation
The ﬁrst category of measures relates to the presentation of tobacco,
alcohol and food products. Generally speaking, all companies tend to
present their goods in such a way as to induce consumers to make
purchase decisions. Packaging is generally the privileged means to
communicate such messages to prospective purchasers: trademarks,
logos, colours, designs and even smells increasingly pervade the pack-
aging in several industries. Therefore, it does not come as a surprise that
more and more regulators and policy-makers around the world includ-
ing the EU have started targeting the packaging of products perceived to
be harmful to people’s health.
The case of tobacco is particularly relevant. Regulatory measures have
recently been proposed or adopted that aim to prevent tobacco compa-
nies from fully exploiting their packaging. In particular, such measures
prohibit companies from fully displaying trademarks, designs, drawings,
colours and other ornamental elements. The aim of these measures is to
discourage consumption of what are considered to be harmful products,
on the assumption that less exposure of existing and potential customers
to tobacco brands and other packaging features reduces the chances of
purchase.3 The most striking examples within this category of measures,
3 See Rebecca Tushnet, ‘Gone in Sixty Milliseconds: Trademark Law and Cognitive
Science’ (2008) 86(3) Texas Law Review 508 (noting in particular that ‘cognitive science
is especially attractive to trademark law because trademark protection is premised on a
psychological assumption: exposure to a mark will trigger ideas and emotions in the mind
of a consumer’).
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as detailed below, are plain packaging and display bans on tobacco
products. I will also brieﬂy comment on a recent dispute regarding a
packaging appropriation measure adopted by Iceland in the ﬁeld of
alcohol and consisting of a ban on the use of some appealing packaging
features of cider cans.
Plain packaging
Also known as ‘generic’ or ‘standardized’ packaging, plain packaging
requires that all forms of tobacco branding be labelled exclusively with
simple, unadorned text. This entails that trademarks, graphics and logos
be removed from cigarette packs, except for the brand name and variant,
which are displayed in a standard font (identical for all brands in
the market). In essence, plain packaging aims at standardizing the
appearance of all cigarette boxes in order to make them unappealing,4
especially for adolescents, thus reducing the prevalence and uptake of
smoking.5
Thus, the practical effect of this measure is to prevent tobacco pro-
ducers from showing the distinctive features of their trademarks,
designs and copyrighted works on cigarette packs. In the eyes of the
tobacco majors, this is a strong limitation on their commercial free-
dom, especially in those countries where almost all forms of tobacco
advertising are prohibited and thus packaging has become their
ultimate marketing tool. Indeed, cigarette packs, once opened, remain
in the hands of ﬁnal consumers and constitute a powerful means of
‘mobile’ advertising.6
4 See Becky Freeman, Simon Chapman and Matthew Rimmer, ‘The Case for the Plain
Packaging of Tobacco Products’ (2007) 103(4) Addiction 580; Alberto Alemanno and
Enrico Bonadio, ‘The Case of Plain Packaging for Cigarettes’ (2010) 3 European Journal
of Risk Regulation 268.
5 Indeed, some independent scientiﬁc evidence shows that this measure – by eliminating
logos, designs and other elements that are capable of inducing people to start smoking – is
likely to reduce tobacco consumption. See Melanie Wakeﬁeld, Daniella Germain,
Sarah Durkin, et al., ‘Do Larger Pictorial Health Warnings Diminish the Need for Plain
Packaging of Cigarettes?’ (2012) 107(6) Addiction 1159–1167; David Hammond,
Samantha Daniel, Christine M. White, ‘The Effect of Cigarette Branding and Plain
Packaging on Female Youth in the United Kingdom’ (2013) 52(2) Journal of
Adoloscent Health 151–157.
6 Plain packaging is endorsed by the FCTC, and more precisely by the guidelines to Articles
11 and 13 to this treaty, which expressly recommend that states consider adopting such
measures. See WHO Framework Convention on Tobacco Control: Guidelines for
Implementation (2011), 59, 95–96 (‘Guidelines to the WHO FCTC’).
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Plain packaging has already been implemented outside Europe, and in
particular by Australia.7 Its adoption has also recently been announced
by Ireland8, the UK and New Zealand and is currently being taken into
consideration by Scotland.9 Also in March 2014 the EU adopted a
revised Tobacco Products Directive. While the directive does not man-
date plain packaging, it leaves EUMember States free to introduce such a
measure, and Ireland and Scotland now seem committed in this regard.10
The above-mentioned Australian legislation has been challenged
by leading tobacco majors such as British American Tobacco
Australasia Limited (‘BAT’) and Philip Morris Asia Limited before
both the High Court of Australia11 and an ICSID arbitral panel con-
stituted pursuant to a bilateral investment treaty (BIT) between
Australia and Hong Kong.12 A dispute is also currently pending at
the World Trade Organization (WTO) with regard to the compatibility
of the Australian measure with several IP provisions of the Agreement
on Trade-Related Aspects of Intellectual Property Rights (‘TRIPS
Agreement’) as well as of the Agreement on Technical Barriers to
Trade (‘TBT Agreement’) because such measure would accord
to imported tobacco products treatment less favourable than accorded
7 Tobacco Plain Packaging Act 2011 (Cth), Ch. 2.
8 See press release of the Irish Minister for Health James Reilly on 28 May 2013, available
at www.dohc.ie/press/releases/2013/20130528.html.
9 See the online edition of The Scotsman, 13 July 2013, available at www.scotsman.com/
news/health/no-excuse-over-delay-on-tobacco-packaging-1-3009408.
10 See the Directive 2014/40/EU of the European Parliament and of the Council of 3 April
2014 on the approximation of the laws, regulations and administrative provisions of the
Member States concerning the manufacture, presentation and sale of tobacco and
related products, 19 December 2012. The main feature of the EU legislation is a require-
ment for tobacco packs to show health warnings covering a minimum of 75% of the front
and back surfaces starting from the top edge; such requirement seems very close to a
generic packaging measure.
11 In August 2012 the Australian proceedings came to an end with the High Court
conﬁrming that the measure did not amount to an expropriation of the tobacco
companies’ (intellectual) property and is thus compliant with the Australian
Constitution (JT International SA v Commonwealth [2012] HCA 43). For a comment
on this decision see Jonathan Liberman, ‘Plainly Constitutional: The Upholding of Plain
Tobacco Packaging by the High Court of Australia’ (2013) 39(2) American Journal of
Law and Medicine 361–381.
12 See the Agreement between the Government of Hong Kong and the Government of
Australia for the Promotion and Protection of Investments, signed on 15 September
1993, 1748 UNTS 385 (entered into force 15 October 1993).
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to similar Australian products and would create unnecessary obstacles
to trade.13
Thus far, legislation on plain packaging has been passed or proposed
with reference to tobacco products. Yet there are speculations that
plain-packaging legislation – or other packaging-related measures –
may in the not-too-distant future spread to food, alcohol and other
products perceived to be harmful, thus enlarging the range of IP rights
owners hit by this marketing restriction. Indeed, there have already been
moves in some countries. For example, Chile has recently proposed an
amendment to its Food Health Regulation which would place ‘STOP’
signs on HFSS foods, such signs occupying no less than 20% of the main
surface of the package.14 Peru introduced a similar legislation in 2013,
i.e. the Act to Promote Healthy Eating amongst Children and
Adolescents, which aims at adding warnings such as ‘high in calories’,
or ‘high salt’ on food products.15 Also, Thailand has in place a liquor-
labelling regime which mandates graphic warnings and accordingly
shrinks the size of the labels.16
Alcohol packaging regulations: Iceland’s experience
A particular packaging-related measure aimed at reducing the attractive-
ness of certain alcoholic products has also recently been adopted
in Iceland. This measure was challenged in the HOB-vìn ehf case
13 In particular, generic packaging could be deemed as a technical regulation more trade-
restrictive than necessary in order to reduce tobacco consumption and thus protect
public health, which would violate Article 2.2 of the TBT Agreement. Indeed, the
introduction of plain packaging would require a scientiﬁc basis or any other sufﬁcient
technical evidence to demonstrate the causal link of such measure with its target. Yet,
Australian authorities claim that such scientiﬁc basis exists in light of the strong
evidence they claim to have collected.
14 See the WTO press release following the latest meeting on 13 March 2013 of the
Technical Barriers to Trade (TBT) Committee.
15 Peru, Act 30.021 to Promote Healthy Eating Among Children and Adolescents, 13 May
2013.
16 In particular, the Thai law requires labels to carry any of the following messages:
(i) drinking alcohol causes hypertension liver cirrhosis; (ii) alcohol intoxication leads
to accidents; (iii) drinking alcohol leads to unconsciousness and even death; (iv) drink-
ing alcohol leads to inferior sexual performance; (v) drinking alcohol leads to adverse
health effect and family problems; (vi) drinking alcohol is a bad inﬂuence on children
and young people. It also requires the graphic health warning to be no less than 30–50%
of the size of the alcohol container. The warning labels shall rotate every 1,000 packages.
See the webpages of the Thai Alcohol and Tobacco Tax and Trade Bureau at www.ttb.
gov/itd/thailand.shtml.
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before the European Free Trade Association Court (‘EFTA Court’)
which found the measure in question was not compliant with the
Agreement on the European Economic Area.17 The most interesting
part of this dispute regards the refusal by the State Alcohol and
Tobacco Company of Iceland (‘ÁTVR’) to authorize the marketing and
sale of three cider products that had been legally manufactured and sold
in Denmark. The reason for such refusal was that their packaging bore
text and visual imagery in violation of a provision adopted by ÁTVR.
That provision states that the text and images on alcohol packaging and
labelling should not: contain loaded or unrelated information; suggest
that the product enhances physical, mental, social or sexual functions; or
offend people’s general sense of propriety, for example by referring to
violence, religion, pornography, illegal drugs, political views, discrim-
ination or criminal conduct. ÁTVR stressed that the packaging of the
products in question – which were marketed in stylish cans, featuring
artful drawings including colourful illustrations of women’s legs with
some apparently naked skin – was ‘evidently intended to make the
products sensually appealing and challenging’.18 The importer of the
cans contested this decision. The case was then referred to the EFTA
Court, which was asked to give an advisory opinion about the compat-
ibility of the Icelandic provision with the EEA Agreement.19 The EFTA
Court noted that the refusal by ÁTVR had been based exclusively on a
speciﬁc part of the rule in question, namely the part of the provision that
prohibits the use of texts or visual imagery that offends people’s general
sense of propriety. Accordingly, it was found that the measure in
17 HOB-vín ehf v The State Alcohol and Tobacco Company of Iceland (ÁTVR) (EFTA Court,
E-2/12, 11 December 2012). For a timely comment on this case see Alberto Alemanno,
‘The HOB-vín Judgment: A Failed Attempt to Standardise the Visual Imagery,
Packaging and Appeal of Alcohol Products’ (2013) 1 European Journal of Risk
Regulation 101. The European Economic Area Agreement was signed on 2 May 1993,
1801 UNTS 3 (entered into force 1 January 1994) (‘EEA Agreement’) and extends
portions of European Union law to European Economic Area countries including
Iceland.
18 HOB-vín ehf v The State Alcohol and Tobacco Company of Iceland (ÁTVR) (EFTA Court,
E-2/12, 11 December 2012) [26].
19 The EFTA Court has the task of interpreting the EEA Agreement with regard to the
EFTA countries that are party to it, namely Iceland, Liechtenstein and Norway. EFTA is
a free trade organization grouping Iceland, Liechtenstein, Norway and Switzerland.
Thus, though not EU member states, Iceland, Liechtenstein and Norway are part of
the EU internal market through the EEA Agreement. Switzerland instead opted to enter
into bilateral agreements with the EU covering many areas, such as movement of
persons, transport and technical barriers to trade.
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question could not, under the EEA Agreement, be justiﬁed by a stringent
public interest objective such as the protection of public health (ÁTVR
had claimed in the proceedings that the ban in question could be justiﬁed
by invoking the protection of consumers’ health).
Even though the Icelandic provision has been condemned for being
contrary to the EEA Agreement, this case shows that policy-makers have
started targeting the packaging of alcoholic products, and they have done
so with a view to reducing the market appeal of such products and thus
reducing their consumption. Yet such measures – which aim at protect-
ing not only public health but also morality and public order – inevitably
restrict the ability of manufacturers to fully exploit their logos, designs or
copyrighted drawings.
Display bans of tobacco products: Norway’s experience
Display bans of tobacco products are another measure that prevents
tobacco companies from fully exploiting their trademarks, designs and
other elements afﬁxed to packaging. This measure entails a ban on
displaying tobacco products at points of sale, which means that tobacco
products cannot be shown to potential purchasers.20 Display bans have
been adopted by several European countries such as Iceland, Norway,
Ireland and Finland in the context of policies aimed at protecting public
health.21 The Norwegian measure, in particular, has been given a green
light by the EFTA Court. On 12 September 2011, the EFTA Court
delivered an advisory opinion conﬁrming the compatibility of the
Norwegian measure with the EEA Agreement. The Court found that
the Norwegian display ban amounts to a restriction on the free move-
ment of goods within the EEA, but that such restriction is justiﬁed as it
protects public health by limiting the consumption of tobacco products
(the ruling does not make reference to IP issues, though).22
20 Display of tobacco products at the point of sale also constitutes a powerful means of
advertising and promotion. As stressed by the Guidelines to the WHO FCTC (see n. 6
above, 94), display of products is a major tool for their promotion, including by
stimulating impulse purchases, giving the impression that tobacco consumption is
socially acceptable and making it more difﬁcult for smokers to quit smoking.
21 Iceland was the ﬁrst country to introduce a display ban of tobacco products, in August 2001.
Norway followed by introducing this measure on 1 January 2010, through an amendment to
the 1973 Act relating to the Prevention of the Harmful Effects of Tobacco (the Tobacco
Control Act). Ireland did the same in July 2009 and Finland in January 2012.
22 Philip Morris Norway AS v Staten/Helse-og omsorgsdepartementet (EFTA Court, E-16/
10, 12 September 2011). For a timely comment on this opinion see Alberto Alemanno,
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Measures restricting advertising
A second category of IP restrictive measures relates to advertising.23 The
EU has already passed legislation prohibiting or restricting advertising of
tobacco, alcohol and unhealthy food. For example, all tobacco advertis-
ing and sponsorship on television has been banned within the EU since
1991 under the Television Without Frontiers Directive.24 This ban was
extended by the Tobacco Advertising Directive, which took effect in July
2005 to cover other forms of media such as the internet, print media,
radio, and sports events like F1. The ban was then extended by the
Audiovisual Media Services Directive (AVMS Directive) to cover prod-
uct placement.25 The AVMS Directive also amends the Television
Without Frontiers Directive in a number of areas including advertising
of unhealthy foods and beverages in children’s programmes, with the
purpose of discouraging the consumption of harmful products by this
category of consumers.26
Again, the effect of these measures is to prevent owners of IP rights
from using their signs, designs or copyrighted works in advertising: take
for example a tobacco manufacturer which had been using a licensed
character in television ads for attracting consumers and has not been
able to exploit it since the introduction of the ban on tobacco advertising;
or those provisions of the AVMS Directive which prohibit not only the
advertising of tobacco products but also the commercial communication
relating to different goods by companies whose core business is tobacco,
e.g. advertising of clothes by a tobacco major (these provisions therefore
clarify that what is banned are the communication activities related to
the tobacco brand itself, regardless of whether such brand is afﬁxed on
‘The Legality, Rationale and Science of Tobacco Display Bans after the Philip Morris
Judgment’ (2011) 4 European Journal of Risk Regulation 591.
23 I am talking here about stricto sensu advertising. Indeed, the many ways in which
companies present their products can also be considered as advertising in its widest
sense.
24 Council Directive 89/552/EEC of 3 October 1989 on the coordination of certain provi-
sions laid down by law, regulation or administrative action inMember States concerning
the pursuit of television broadcasting activities.
25 Directive 2010/13 on the coordination of certain provisions laid down by law, regulation
or administrative action in Member States concerning the provision of audiovisual
media services (AVMS) [2010] OJ L95/1.
26 See Articles 9(1)(e) and 9(2) of the AVMS Directive. For a critical comment of these
provisions see Olivier Bartlett and Amandine Garde, ‘Time to Seize the (Red) Bull by the
Horns: The European Union’s Failure to Protect Children from Alcohol and Unhealthy
Food Marketing’ (2013) 38 European Law Review 498–520.
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products other than cigarettes).27 To the eyes of the industry, said meas-
ures constitute a clear limitation of the IP owners’ commercial freedom and
in particular of the ability to use their protected asset in advertising.28
Limiting availability of products to consumers
Other restrictive measures relate to the supply of the products to ﬁnal
consumers. For example, some non-EU countries have limited the times
during which alcoholic products are sold, or use authorization systems
to limit the number of shops and places that can sell such products.29
This category also includes measures that prohibit or make it more
difﬁcult to sell tobacco and alcohol to minors, for example bans of
tobacco or alcohol vending machines30 or bans on the sale of tobacco
with or in sweets, snacks, toys or any other objects that appeal to
minors.31
All these measures restrict the freedom of manufacturers/IP rights
owners, and their distributors, to sell their IP-protected products or to
choose innovative ways of supplying their products, and limit the num-
ber of ﬁnal consumers available to such companies by excluding a
category of potential purchasers. This also restricts the ability of such
companies to show their trademarks and other IP assets to a larger range
of current and prospective clients, thus limiting them in fully using and
exploiting the said assets.
Measures related to manufacturing
Another category of restrictive measures relates to the manufacturing of
the products in question. Take the bans or restrictions on the use of
27 See Recital 88 and Articles 10(2) and 11(4)(a) of the AVMS Directive.
28 See for example Article 5 of Directive 2008/95/EC of the European Parliament and of the
Council of 22 October 2008 to approximate the laws of the Member States relating to
trade marks (Codiﬁed version), which offers trademark owners the exclusive right, inter
alia, to prevent others from afﬁxing the sign to the goods or to the packaging thereof and
using the sign in advertising.
29 Countries which have restricted the availability of alcoholic products include
Bangladesh, Brunei, some states of India and Pakistan.
30 Vending machines also constitute a means of advertising or promotion (see WHO
FCTC, Article 16). Several EU countries have banned vending machines, including
Slovakia, Slovenia, Croatia, Greece, Cyprus, Estonia, Hungary, France, Latvia,
Lithuania, Poland and Romania.
31 These measures are recommended by Article 16 of the WHO FCTC.
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certain ingredients, including trans-fats, in foodstuffs;32 or the bans on
the use of ﬂavouring or colouring agents in tobacco and alcoholic
products33 which help make them more attractive.34
If a product or manufacturing process that includes the prohibited
ingredient is patented, such a ban would make the patent meaningless as
the producer/IP right owner would be prevented from properly using the
invention. Concerns are growing, as patents covering food products and
processes, and food and beverage recipes, are more and more frequently
granted. Patent applications also show that some ingredients associated
with energy and vitality, such as caffeine and taurine (which are increas-
ingly viewed with suspicion by regulators),35 have also been considered
for use in tobacco products.
Plain packaging of tobacco products may also make pack-related
patents and three-dimensional designs meaningless. For example, new
Australian legislation requires that cigarette packs shall not contain an
opening, such as a ﬂiptop lid, that can be reclosed or resealed after the
32 While Denmark and Finland have introduced limits to the amounts of trans-fats in
foodstuffs, the EU has not yet done so. As stressed by Article 30(7) of the Regulation on
the Provision of Food Information to Consumers (Regulation No. 1169/2011), the
Commission, taking into account scientiﬁc evidence and experience acquired in
Member States, shall submit a report on the presence of trans-fats in foods and in the
overall diet of the EU population. The aim of the report shall be to assess the impact of
appropriate measures that could allow consumers to make healthier food and overall
dietary choices or that could promote the provision of healthier food options to con-
sumers, including restrictions on the use of trans-fats.
33 See Article 7 of the 2014/40/EU Directive of the European Parliament and of the Council
on the approximation of the laws, regulations and administrative provisions of the
Member States concerning the manufacture, presentation and sale of tobacco and
related products, which states that ‘Member States shall prohibit the placing on the
market of tobacco products with a characterising ﬂavour’. Examples of ﬂavouring
substances in tobacco products include benzaldehyde, maltol, menthol and vanillin:
see Guidelines to the WHO FCTC, above n. 6, 39. Examples of colouring agents in
tobacco products include inks (for example, imitation cork pattern on tipping paper)
and pigments (for example titanium dioxide in ﬁlter material), above n. 6, at 40.
34 As noted by the Guidelines to the WHO FCTC (see n. 6 above, 39), some tobacco products
also contain added sugars and sweeteners (such as glucose, molasses, honey and sorbitol)
which improve the palatability of tobacco products to tobacco users. The Guidelines to the
WHO FCTC (at 40) also encourage states to introduce bans on ingredients in tobacco
products that help to create the impression that the products have health beneﬁts or that they
present reduced health hazards (such ingredients include vitamin C and vitamin E, fruit and
vegetables, amino acids and essential fatty acids).
35 For example, France banned the well-known energy drink Red Bull for twelve years due
to health authorities’ concerns about unknown consequences of taurine (the ban was
lifted in 2008).
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pack is ﬁrst opened.36 It also requires that the outer faces of retail
packaging shall not have any decorative ridges, embossing, bulges or
other irregularities of shape or texture.37 As noted by Gummow J in the
decision of the High Court of Australia, which conﬁrmed the lawfulness
of plain packaging under the Australian Constitution, this regulatory
measure denies the exploitation of the patent owned by BAT. BAT’s
patent covers an invention titled ‘Smoking article packaging’, and refers
to a method of resealing the contents in that packaging.38 The measure
also makes meaningless BAT’s registered design protecting the so-called
‘ribbed pack’, the characteristic features of which reside in its particular
shape and conﬁguration.39
The compatibility of the regulatory measures with IP rights
This analysis demonstrates that measures aimed at restricting the man-
ufacture, presentation, advertising and supply of tobacco, alcohol and
unhealthy food and beverages can potentially jeopardize the ability of
manufacturers to exploit their IP. They may do so in different phases of
the production chain that eventually brings the product into the hands
of consumers, from the manufacturing process to the supply to end-
users. Do such interferences violate IP rights?40 On the one hand,
manufacturers may stress that as these restrictive measures prevent
them from fully using their IP assets, they encroach upon the rights
offered to them by trademark, patent and design registration law, as well
as copyright law provisions.
36 Tobacco Plain Packaging Regulations 2011 (Cth), reg 2.1.1.
37 Tobacco Plain Packaging Act 2011 (Cth), s 18(1)(a).
38 British American Tobacco (Investments) Limited, Smoke Article Packaging, Australian
Patent No. 2001258572 (22 May 2001).
39 A category that does not have a direct impact on IP is that of measures governing the
consumption of the products in question. Examples include bans on smoking in public
spaces already adopted in many EU countries as well as price increases and consumption
taxes (which are introduced by governments tomake unhealthy products such as alcohol and
tobacco less affordable). Whilst such measures do not jeopardize the ability of IP rights
owners to use their intangible assets – they just limit the use of the products by ﬁnal
consumers – they might however have an indirect impact on IP as they may cause
manufacturers/IP rights owners to lose sales. This in turn makes it more difﬁcult for them
to recoup the investments needed to come up with the relevant logos, designs or inventions
and/or obtain the relevant IP protection, that is trademark or patent registration.
40 We have already seen that in the HOB-vín ehf case the EFTA Court found the Icelandic
provision in question in violation of the EEA Agreement. However, the rules examined
by the EFTA Court in that case were not IP related.
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Yet, it could also be argued that thesemeasures do not encroach upon the
rights offered to IP rights owners and therefore cannot be considered legally
incompatible with the IP rights system. A look at most national, EU and
international provisions on the scope of IP protection reinforces this
belief.41 Such provisions clarify that IP rights holders do not have a positive
right to actually use the IP assets – they are just given a ius excludendi alios,
that is the negative right to prevent third parties from using the asset.42 The
use of trademarks, designs, inventions and copyrighted works can thus be
prohibited or restricted by measures adopted on public interests grounds,
such as the ones analysed in this chapter. This is exactly what has occurred
in many jurisdictions as far as tobacco products are concerned. Indeed
many countries (including European ones), in the context of public health
protection programmes, have adopted advertising restrictions entailing a
prohibition of the use of tobacco trademarks under certain circumstances.
These measures have not raised any doubts about their compatibility with
national, European and international provisions protecting trademarks and
other IP rights. This is due, I believe, to the fact that most IP laws in the
world, including EU IP legislation, do not offer IP rights holders any positive
right to use their protected assets.43
The above argument is disputed by some commentators, who consider
it too formalistic and mistaken in permitting a right of registration but
at the same time denying a right of use. Such an interpretation is argued
as risking the undermining of the IP system and contrary to the spirit
of IP legislations.44 According to this school of thought, therefore, IP
41 See, e.g., Directive 2008/95/EC of the European Parliament and of the Council of
22 October 2008 to approximate the laws of the Member States relating to trade
marks [2008] OJ L 299/25, Article 5(3); TRIPS Agreement, Art. 16(1); Directive 98/
44/EC of the European Parliament and of the Council of 6 July 1998 on the legal
protection of biotechnological inventions [1998] OJ L 213/13, recital 14.
42 See also Mark Davison, ‘The Legitimacy of Plain Packaging under International
Intellectual Property Law: Why there is no Right to Use a Trademark under either the
Paris Convention or the TRIPS Agreement’ in Andrew Mitchell, Tania Voon and
Jonathan Liberman (eds.), Public Health and Plain Packaging of Cigarettes: Legal
Issues (Edward Elgar, 2012), noting that neither the TRIPS Agreement nor the Paris
Convention for the Protection of Industrial Property, opened for signature 14 July 1967,
828 UNTS 306 (entered into force 26 April 1970), expressly provide for a right to use IP
rights and in particular trademarks.
43 See for example Article 5 of Directive 2008/95/EC of the European Parliament and of the
Council of 22 October 2008 to approximate the laws of the Member States relating to
trade marks (Codiﬁed version).
44 See Patrick Basham and John C. Luik, Erasing Intellectual Property: ‘Plain Packaging’
for Consumer Products and the Implications for Trademark Rights (Democracy
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registrations confer an implied positive right to use the protected asset.45
This reasoning seems ﬂawed though. Indeed, the right to commercially
use a sign or an invention arises not from the registration (either directly
nor indirectly),46 but is rather a characteristic intrinsic to the freedom to
carry out commercial activities in the market,47 such freedom being
capable of being restricted on public interest grounds, such as the
protection of public health.
That IP rights, and in particular trademarks, offer their owners neg-
ative rights has been reafﬁrmed by Advocate General Geelhoed in his
Opinion in British American Tobacco,48 where he stated:
[T]he essential substance of a trademark right does not consist in an
entitlement as against the authorities to use a trademark unimpeded by
provisions of public law. On the contrary, a trademark right is essentially
a right enforceable against other individuals if they infringe the use made
by the holder.49
Following this interpretation, it seems that the restrictive measures
highlighted in this chapter – that is, ‘provisions of public law’ –
would not breach IP rights as they do not authorize third parties to
exploit IP protected assets; they merely consist of lawful restrictions on
the ability of rights owners to use their own signs, logos or copyrighted
works. Yet, despite this limitation, rights holders could still exercise the
Institute, Washington Legal Foundation, 2011), 22–29. See also Daniel Gervais,
Analysis of the Compatibility of Certain Tobacco Product Packaging Rules with the
TRIPS Agreement and the Paris Convention (30 November 2010), Physicians for a
Smoke-Free Canada, available at www.smoke-free.ca/trade-and-tobacco/Resources/Ge
rvais.pdf, 11–12 (‘Gervais Report’); Annette Kur, ‘The Right to Use One’s Own Trade
Mark: A Self-evident Issue or a New Concept in German, European, and International
Trade Mark Law?’ (1996) 4 European Intellectual Property Review 203; Memorandum
from Lalive to Philip Morris International Management SA, 23 July 2009, available
at www.smoke-free.ca/plain-packaging/documents/industry-responses/LALIVE_Analy
sis_23_July_2009.pdf.
45 See, as far as trademarks are concerned, the Gervais Report, ibid.
46 This is particularly true in the ﬁeld of copyright. Indeed, in most jurisdictions copyright
legislation offers rights owners exclusive rights from the date the work is created,
regardless of any registration.
47 See Kur, n. 44 above, 199.
48 See R v Secretary of State for Health, ex parte British American Tobacco (Investments) Ltd
and Imperial Tobacco Ltd (Advisory Opinion of Advocate-General Geelhoed) (C-491/01)
[2002] ECR I-11453; Directive 2001/37/EC of the European Parliament and of the
Council of 5 June 2001 on the approximation of the laws, regulations and administrative
provisions of the Member States concerning the manufacture, presentation and sale of
tobacco products [2001] OJ L 194/26.
49 (C-491/01) [2002] ECR I-11453, ibid. [266].
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right to prohibit the misappropriation of their assets by unauthorized
third parties.
How to use IP regimes for encouraging the production
of healthier food and beverages: three proposals
The previous sections discussed the (negative) impact on IP of certain
regulatory measures aimed at discouraging the manufacture, sale and
consumption of harmful products, whether they be cigarettes, alcohol or
unhealthy food or beverages. It has been argued that such an impact,
despite being negative, entails no violation of IP rights.
It is now time to verify if, and to what extent, IP regimes (in and
outside Europe) may contribute to incentivizing companies to manu-
facture and market healthier products in the ﬁelds of food and beverages.
The need to supply customers with healthier food and beverages con-
stitutes an urgent need as many people in both industrialized and
developing countries struggle with obesity (which is mostly caused by
unhealthy diets), its related diseases, and other illnesses caused by con-
sumption of unhealthy products.
The IP system may play a role, including in the EU, in ﬁghting obesity
and related illnesses. Three proposals are put forward, which aim at
amending patent procedures for inventions related to foodstuffs and
beverages. Such proposals seem to be pertinent and timely as food-
and beverages-related patents are increasingly granted around the
world. There is little doubt that food and beverages recipes can be
patented provided that they comply with patentability requirements, as
has been conﬁrmed recently by the Supervisory Patent Examiner of the
United States Patent and Trademark Ofﬁce.50
The ﬁrst proposal would require food and beverage manufacturers
that want to patent their products or processes to show that the products
or processes contain or use healthy ingredients. The same burden is the
focal point of the second and third proposals; yet in these cases fulﬁlling
such a requirement would not constitute the sine qua non condition for
patent protection. Rather, it would just aim at speeding up or facilitating
the patenting process for foods and beverages that are considered
healthy.
50 See Larry Taravano, ‘Can Recipes be Patented?’, InventorsEye (The USPTO’s bimonthly
publication for the independent inventor community), June 2013, available at www.uspto.
gov/inventors/independent/eye/201306/ADVICE.jsp.
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Requiring food and beverage patent applicants
to demonstrate use of healthy ingredients
The ﬁrst proposal would be to make the patenting of inventions related
to foodstuffs and beverages subject to both (i) the presence in the
relevant products or processes of macronutrients including proteins,
vitamins and carbohydrates; and (ii) a signiﬁcant reduction of unhealthy
ingredients such as salt, fat and sugar. In other words, this proposal
would require applicants to show that their foodstuffs and beverages are
healthy and do not contain harmful ingredients or components. Further,
a patent covering an invention that does not satisfy the proposed con-
ditions should be invalidated. It is believed that such a requirement
would be a workable one, especially in light of the fact that some patents
covering healthy food have been granted in the past. The US Patent No.
5260087 for an invention entitled ‘Fat and egg yolk substitute for use in
baking and process for using substitute’ is a case in point:51 indeed, as is
explained in the patent speciﬁcation, fats and eggs produce desirable
taste and sensory qualities in the baked goods, but also contribute much
fat and cholesterol to the baked items. And the main purpose of this
invention is to provide a low-fat compound which can be used in baking
cookies and cakes as a substitute for fats and egg yolks, while still
producing the desired product taste and sensory qualities. The invention
further aims to provide a very low-fat compound and a method of using
it that will not only produce a tasty and tender baked item, but will also
contribute to increased item shelf life.
The requirement in question could be justiﬁed by relying on a provi-
sion contained in many international, regional and national patent
legislations that state that countries are allowed to exclude from patent-
ability inventions that are contrary to ordre public and morality. For
example, Article 53(a) of the European Patent Convention states that
‘European patents shall not be granted in respect of . . . inventions the
commercial exploitation of which would be contrary to “ordre public” or
morality.’52 It could indeed be argued that inventions related to unheal-
thy food and beverages should be excluded from patentability on the
above grounds (also, the concept of ‘ordre public’ could be broadened by
extending the list of grounds to include other reasons of overriding
public interest, such as health protection). The proposal also seems to
51 This US patent was ﬁled in July 1992 and has therefore expired.
52 Convention on the Grant of European Patents, opened for signature 5 October 1973, 1065
UNTS 199 (entered into force 7 October 1977); see also TRIPS Agreement, Article 27(2).
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be in line with the very purpose of the patent system, which is to
incentivize the realization of inventions that are really useful to societies.
From a procedural perspective, I would propose that applicants make
a reasonable, written assertion that the products or processes for which
they seek a patent are healthy. Food and beverage products and processes
for which health beneﬁts are immediately clear would just need a simple
statement. More detailed clariﬁcations should be required for less obvi-
ously healthy inventions – and their healthiness should be conﬁrmed by
the patent ofﬁce.53
Having said that, it might be argued that this proposal would be
contrary to Article 62(1) of the TRIPS Agreement, which states that
‘Members may require, as a condition of the acquisition or maintenance
of the intellectual property rights . . . compliance with reasonable proce-
dures and formalities.’54 Thus, making the patenting of food- and
beverage-related inventions subject to the above-mentioned require-
ment may amount to an unreasonable condition on the acquisition or
maintenance of the relevant patent. Also, it may be noted that introduc-
ing this condition only with reference to food and beverages related
inventions would violate the principle of non-discrimination between
ﬁelds of technology pursuant to Article 27(1) of the TRIPS Agreement.
This provision clariﬁes that ‘patents shall be available and patent rights
enjoyable without discrimination as to . . . the ﬁeld of technology’.
Yet it is arguable that this proposal would not constitute an unreason-
able condition on the acquisition of patents on food- and beverage-
related inventions as it would not place excessively heavy burdens on
patent ofﬁces and applicants. The objection that patent ofﬁces and
judges would not be well-equipped to verify whether the product or
process in question is healthy (indeed one may note that such a task
53 These suggestions build upon some observations made by the Californian IP lawyer Eric
Lane in connection with green technologies: see Eric Lane, ‘Building the Global Green
Patent Highway: A Proposal for International Harmonization of Green Technology Fast
Track Programs’ (2012) 27(3) Berkeley Technology Law Journal 1119, at 1147–1150; see
also Lane, Clean Tech Intellectual Property: Eco-marks, Green Patents, and Green
Innovation (Oxford University Press, 2011), 218–226.
54 (Emphasis added). This provision has been interpreted by a WTO Panel in Canada –
Term of Patent Protection, WT/DS170/R, Report of 5 May 2000. The Panel held that
some Canadian patent law provisions (which required applicants to resort to delays such
as abandonment of the application, reinstatement, non-payment of fees and non-
response to a patent examiner’s report) would be inconsistent with the general principle
that procedures should not be unnecessarily complicated, as expressed in inter alia
Article 62.1 of the TRIPS Agreement (paras 6.117–6.119).
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exceeds the skills of patent ofﬁces) could be overcome. For example,
patent ofﬁcers could team up with experts (such as professors in food
science) who could be questioned about technical issues. The latest
developments in food safety would help overcome the scientiﬁc, social
and cultural uncertainties that have thus far surrounded the distinction
between healthy and unhealthy food. Indeed, efforts have recently been
made by regulators to devise an appropriate categorization system that
allows for the differentiation of foods which are high in fat, saturated
fat, salt or sugar.55 For example, the UK Food Standards Agency has
developed a nutrient-proﬁling model as a tool for categorizing foods on
the basis of objective criteria and in particular their nutrient content.56
This model, which has been adopted by the UK media and communi-
cations regulator Ofcom to regulate the advertising and promotion of
foods to children, uses a simple scoring system that recognizes the
contribution made by beneﬁcial nutrients that are important in a child’s
diet (i.e. protein, ﬁbre, fruit and vegetables, and nuts) and puts at a
disadvantage foods with ingredients that children should eat less of
(saturated fats, salt and sugars).57 A similar scoring system could be
used in patenting procedures for foodstuffs and beverages, with
applicants failing to reach a certain threshold being refused the patent.
Also, the proposal in question should be considered reasonable
because it aims at pursuing an overriding public interest, which is to
incentivize the production of healthy food and beverages and thus ﬁght
55 Generally speaking, it is widely accepted that energy-dense, micronutrient-poor foods,
which are high in fat, sugar or salt are not nutritious and may be detrimental to human
health: see Marine Friant-Perrot and Amandine Garde, ‘From BSE to Obesity – EFSA
Growing Role in the EU’s Nutrition Policy’ in Alberto Alemanno and Simone Gabbi
(eds.), Foundations of EU Food Law and Policy – Ten Years of the European Food Safety
Authority (Farnham: Ashgate, 2014).
56 See the UK Food Standards Agency webpages at www.food.gov.uk/northern-ireland/
nutritionni/niyoungpeople/nutlab/#.Ugn2GVMgYfo.
57 Some progress has also been made at EU level. For example, despite the difﬁculties
experienced by the European Food Safety Authority (EFSA) in performing its nutrition-
related tasks, said agency has nonetheless provided scientiﬁc advice on the establishment
of tolerable upper levels of intakes (UL) for vitamins and minerals representing the
highest level of daily intake likely to pose no risk to health (see Tolerable Upper Intake
Levels for Vitamins and Minerals by the Scientiﬁc Panel on Dietetic Products, Nutrition
and Allergies (NDA) and Scientiﬁc Committee on Food (SCF), February 2006, available
at www.efsa.europa.eu/it/ndatopics/docs/ndatolerableuil.pdf). Also, in 2010 EFSA
established dietary reference values for carbohydrates, dietary ﬁbre, fats and water (see
EFSA press release of 26 March 2010, available at www.efsa.europa.eu/en/press/news/
nda100326.htm).
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obesity and related illnesses. As is well-known, the furtherance of public
interests is one of the objectives pursued by the TRIPS Agreement,
Article 8 of which states that:
Members may, in formulating or amending their laws and regulations,
adopt measures necessary to protect public health and nutrition, and to
promote the public interest in sectors of vital importance to their socio-
economic and technological development.
It could be further argued that the proposed measure does not constitute
discriminatory treatment vis-à-vis the food and beverage sector, but that
it boils down to lawful differential treatment that is necessary to meet a
socially sensitive objective in speciﬁc ﬁelds – here, the protection of
public health. The distinction between unlawful ‘discrimination’ and
lawful ‘differential treatment’ in the ﬁeld of IP rights has already been
stressed by the WTO Panel in Canada – Patent Protection for
Pharmaceutical Products.58 In that case the Panel stated that ‘Article 27
does not prohibit bona ﬁde exceptions to deal with problems that may
exist only in certain product areas.’ In this respect, Frederick Abbott
points out that if speciﬁc rules applicable only to pharmaceutical patents
are necessary to address important public interests such as the protection
of public health, ‘this does not constitute “discrimination” against the
ﬁeld of pharmaceutical technology. It constitutes recognition of legit-
imate public interests in differential treatment’.59 This statement has
been made in relation to pharmaceutical inventions, but it could argu-
ably also be invoked in relation to food- and beverage-related products
and processes. Indeed the proposed condition aims to meet socially
relevant aims in the ﬁeld of public health, especially the ﬁght against
obesity and related diseases.
Fast-track procedures for healthy food and beverage
patent applications
The second proposal is to set up a fast-track procedure for patent applica-
tions covering foodstuffs and beverages containing macronutrients or other
58 Panel Report, Canada – Patent Protection of Pharmaceutical Products, WTO Doc WT/
DS114/R (17 March 2000) [7.92].
59 See Frederick Abbott, ‘Compulsory Licensing for Public Health Needs: The TRIPS
Agenda at the WTO after the Doha Declaration on Public Health’ (Occasional Paper
No. 9, Friends World Committee for Consultation, February 2002), 49–50, available at
www.cptech.org/ip/health/cl/quno-op9.pdf.
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healthy ingredients so as to provide an expedited examination of the
relevant patentability requirements. This proposal would again aim at
protecting public health. Analogous procedures are being or have been
established in the ﬁeld of green technologies in the United States, the
United Kingdom, South Korea, Israel, Canada and Japan.60
Applicants that ask for this fast-track procedure must show that their
products or processes both contain healthy ingredients and lack unheal-
thy components (again, should applicants fail to reach a certain scoring
threshold, the patent would be refused), and in cases where the health
beneﬁts are clear a brief statement by the claimant would satisfy this
requirement.
It would be wise to devise this fast-track procedure in the context of an
international treaty. This would be recommended in order to overcome
possible differences between national procedures (which could vary
widely in their rules and requirements). As a matter of fact, such
disparities would make participation in multiple fast-track programmes
expensive and lengthy, as applicants who want to protect their inven-
tions in multiple jurisdictions would have to comply with many different
rules. An international harmonized fast-track programme, with similar
rules and requirements, would instead eliminate substantial burdens on
applicants and thus speed up and make cheaper the patenting process for
healthy food and beverage products. It would therefore also boost par-
ticipation. A similar proposal has already been put forward with regard
to fast-track programmes for green technologies-based inventions.61
What should be avoided is the setting up of a fast-track programme
based on a rigid classiﬁcation system that ‘crystallizes’ the categories of
inventions that are eligible for fast-track procedures. The risk of such a
system might be that foodstuffs or beverages containing healthy ingre-
dients or constituents not mentioned in a particular category may not be
eligible as they do not fall into one of the preselected classiﬁcations. Also,
additional burdens on applicants should be avoided, such as conducting
prior article searches and analysis. In such a way the entire process
would be accelerated.62 Such a system and such requirements would
60 The ﬁrst country to launch this programme was the UK inMay 2009 (see press release, UK
Intellectual Property Ofﬁce, ‘UK “Green” Inventions to get Fast-Tracked through Patent
System’, available at www.ipo.gov.uk/about/press/press-release/press-release-2009/press-
release-20090512.htm).
61 Lane, ‘Building the Global Green Patent Highway’, n. 53 above, 1160–1170.
62 Again these suggestions build upon some observations made by Eric Lane in connection
with green technologies: see ibid., 1138–1145.
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surely amount to ‘reasonable procedures and formalities’, as required by
Article 62(1) of the TRIPS Agreement, as they would speed up and
make less costly and time-consuming the whole patent procedure for
food- and beverage-related inventions. Again, in order to overcome the
objection that patent ofﬁces would not be well-equipped to verify
whether a food- or beverage-related invention is really healthy, it
would be advisable to partner patent ofﬁcers with technical experts
able to distinguish and categorize foods on the basis of objective criteria,
and in particular their nutrient content. Also, the proposed system
would not violate the above-mentioned Article 27(1) of the TRIPS
Agreement for the reasons already highlighted in the previous section.
Exempting healthy food and beverage patent applications from fees
The third proposal would entail exempting applicants for patents covering
healthy food- and beverage-related inventions from paying the patent
procedures fees – or at least signiﬁcantly reducing them (again, applicants
should show that their foodstuffs and beverages are healthy and do not
contain harmful ingredients or components). This proposal would there-
fore aim at facilitating the patent protection of healthy foodstuffs and
beverages. Indeed, patent fees may sometimes be unaffordable, especially
for small andmedium-sized enterprises. Take for example the high number
of fees required by the European Patent Ofﬁce, for example ﬁling
fees, search fees, fees per designated state, fees per claim over ten claims,
examination fees and a fee for the patent grant and printing.
This proposal could also be ‘merged’ with the previous one. For
example, countries particularly keen on protecting public health could
both set up a fast-track patent procedure for healthy food and beverages
and exempt applicants from paying the relevant fees (or greatly reduce
them).
Conclusion
In the past years new regulatory actions adopted in Europe and beyond
have tended to restrict the freedom of tobacco, alcohol and food com-
panies to produce, present, offer for sale, advertise and supply their
products as they wish, limiting their commercial freedom. Yet such
measures are considered by many governments and international and
non-governmental organizations as necessary to protect an overriding
public interest, that is, human health. The measures in question,
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however, jeopardize the ability of producers to fully use and exploit their
IP assets. Yet, such inability does not necessarily mean that these meas-
ures encroach upon IP rights. Indeed, the negative nature of these
rights – which give their owners the power to prevent unauthorized
uses of their assets – allows states to take regulatory IP restrictive action
on public interest grounds.
Furthermore, national patent laws (within and outside Europe) could
be modiﬁed in such a way as to protect public health, especially in the
ﬁeld of foodstuffs and beverages. The proposals put forward in this
chapter aim at amending patent procedures with a view to eventually
encouraging the manufacture and entry into the market of foodstuffs
and beverages that contain healthy ingredients and constituents. As
demonstrated, these proposals may be compliant both with the aim of
the patent system and with several provisions, including patent-related
rules, of the TRIPS Agreement.
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